28 related articles for article (PubMed ID: 38484950)
1. Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway.
Pei Y; He Y; Wang X; Xie C; Li L; Sun Q; Liu L; Shan S; Wang P; Liu T; Fan X; Cong M; Jia J
Eur J Pharmacol; 2024 Jul; 975():176668. PubMed ID: 38788791
[TBL] [Abstract][Full Text] [Related]
2. Excessive fatty acids activate PRMT5/MDM2/Drosha pathway to regulate miRNA biogenesis and lipid metabolism.
Hou A; Xu X; Zhang Y; He H; Feng Y; Fan W; Tan R; Gong L; Chen J
Liver Int; 2024 Jul; 44(7):1634-1650. PubMed ID: 38517158
[TBL] [Abstract][Full Text] [Related]
3. Pueraria lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress.
Dong H; Zhao Y; Teng H; Jiang T; Yue Y; Zhang S; Fan L; Yan M; Shao S
J Ethnopharmacol; 2024 Jun; 333():118468. PubMed ID: 38906339
[TBL] [Abstract][Full Text] [Related]
4. CNOT7 regulates lipid deposition in nonalcoholic fatty liver disease.
Li J; Wen W; Li J; Liu T; Sun J; Chen H
Biochem Biophys Res Commun; 2024 Aug; 721():150003. PubMed ID: 38772212
[TBL] [Abstract][Full Text] [Related]
5. PCB169 exposure aggravated the development of non-alcoholic fatty liver in high-fat diet-induced male C57BL/6 mice.
Wei Y; Zhou G; Lv G; Wei W; Shera L; Lin H; Chen J; Kang D
Front Nutr; 2024; 11():1350146. PubMed ID: 38779445
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and mechanism of action of Yanxiao Di'naer formula for non-alcoholic steatohepatitis treatment based on metabolomics and RNA sequencing.
Zheng DX; Hou Q; Xue TT; Gao X; Geng RY; Wen LM; Wang Z; Yin Q; Yin HL; Hu JP; Yang JH
J Ethnopharmacol; 2024 Jun; 333():118487. PubMed ID: 38925322
[TBL] [Abstract][Full Text] [Related]
7. CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression.
Terry AR; Nogueira V; Rho H; Ramakrishnan G; Li J; Kang S; Pathmasiri KC; Bhat SA; Jiang L; Kuchay S; Cologna SM; Hay N
Cell Metab; 2023 Nov; 35(11):2060-2076.e9. PubMed ID: 37852255
[TBL] [Abstract][Full Text] [Related]
8. Huang Zhen mycoplasm polysaccharides mitigate nonalcoholic fatty liver disease induced by a high-fat diet in mice: Evidence from hepatic metabolomics.
Wu Y; Xu F; Song Z; Jiang H; Li S; Huo G; Hua C
Int J Biol Macromol; 2024 Jun; 273(Pt 1):132889. PubMed ID: 38844288
[TBL] [Abstract][Full Text] [Related]
9. Silibinin, a commonly used therapeutic agent for non-alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19.
Bai Y; Zhang J; Li J; Liao M; Zhang Y; Xia Y; Wei Z; Dai Y
Br J Pharmacol; 2024 Jun; ():. PubMed ID: 38839561
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticle encapsulated oleic acid induced lipotoxicity to hepatocytes via ROS overload and the DDIT3/BCL2/BAX/Caspases signaling in vitro and in vivo.
Liu YN; Zhu HX; Li TY; Yang X; Li XJ; Zhang WK
Free Radic Biol Med; 2024 Jun; ():. PubMed ID: 38945456
[TBL] [Abstract][Full Text] [Related]
11. 4,4-Dimethylsterols Reduces Fat Accumulation via Inhibiting Fatty Acid Amide Hydrolase In Vitro and In Vivo.
Zhang T; Xie L; Guo Y; Wang Z; Guo X; Liu R; Jin Q; Chang M; Wang X
Research (Wash D C); 2024; 7():0377. PubMed ID: 38812531
[TBL] [Abstract][Full Text] [Related]
12. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
[TBL] [Abstract][Full Text] [Related]
13. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
14. Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway.
Liu Y; Li Y; Wang J; Yang L; Yu X; Huang P; Song H; Zheng P
BMC Complement Med Ther; 2022 Aug; 22(1):213. PubMed ID: 35945571
[TBL] [Abstract][Full Text] [Related]
15. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
16. New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.
Shores DR; Binion DG; Freeman BA; Baker PR
Inflamm Bowel Dis; 2011 Oct; 17(10):2192-204. PubMed ID: 21910181
[TBL] [Abstract][Full Text] [Related]
17. Extract of Silphium perfoliatum L. improve lipid accumulation in NAFLD mice by regulating AMPK/FXR signaling pathway.
Xu J; Jia W; Zhang G; Liu L; Wang L; Wu D; Tao J; Yue H; Zhang D; Zhao X
J Ethnopharmacol; 2024 Jun; 327():118054. PubMed ID: 38484950
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
